Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|15 Jun 2018||Submitted||Original manuscript|
|16 Aug 2018||Reviewed||Reviewer Report - Bjørn Tore Gjertsen|
|31 Aug 2018||Reviewed||Reviewer Report - Reviewer 2|
|8 Oct 2018||Author responded||Author comments - Nuno Cerveira|
|Resubmission - Version 2|
|8 Oct 2018||Submitted||Manuscript version 2|
|15 Oct 2018||Reviewed||Reviewer Report - Bjørn Tore Gjertsen|
|29 Oct 2018||Reviewed||Reviewer Report - Reviewer 2|
|14 Nov 2018||Author responded||Author comments - Nuno Cerveira|
|Resubmission - Version 3|
|14 Nov 2018||Submitted||Manuscript version 3|
|16 Nov 2018||Editorially accepted|
|7 Dec 2018||Article published||10.1186/s12885-018-5100-4|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.